{"id":2144646,"date":"2026-01-23T05:00:00","date_gmt":"2026-01-23T10:00:00","guid":{"rendered":"https:\/\/kffhealthnews.org\/?post_type=article&#038;p=2144646"},"modified":"2026-01-23T07:49:52","modified_gmt":"2026-01-23T12:49:52","slug":"mifepristone-medication-abortion-pill-trump-fda","status":"publish","type":"article","link":"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/","title":{"rendered":"Why Medication Abortion Is the Top Target for Anti-Abortion Groups in 2026"},"content":{"rendered":"\n<aside class=\"block--sidebar alignright \">\n\t\n\n<div class=\"wp-block-kaiser-health-news-promo is-style-classic block--type--promo-block alignnone\"><div class=\"promo-block--image\"><a class=\"promo-block--link\" href=\"https:\/\/kffhealthnews.org\/topics\/healthbent\/\"><img decoding=\"async\" src=\"https:\/\/khn.org\/wp-content\/uploads\/sites\/2\/2020\/09\/Rovner-Julie2022_3x2.jpg\" alt=\"\" data-id=\"1624082\" data-size=\"medium\" \/><\/a><\/div><div class=\"promo-block--inner\"><h3 class=\"promo-block--title\"><a class=\"promo-block--link\" href=\"https:\/\/kffhealthnews.org\/topics\/healthbent\/\">About &#8216;HealthBent&#8217;<\/a><\/h3><p class=\"promo-block--excerpt\">KFF Health News chief Washington correspondent Julie Rovner, who has covered health care for more than 30 years, offers insight and analysis of policies and politics in her regular HealthBent columns.<br><br>Send questions to\u00a0<a href=\"mailto:jrovner@kff.org\" data-type=\"mailto\" data-id=\"mailto:jrovner@kff.org\" target=\"_blank\" rel=\"noreferrer noopener\">jrovner@kff.org<\/a>.<\/p><a class=\"promo-block--read-more promo-block--link\" href=\"https:\/\/kffhealthnews.org\/topics\/healthbent\/\">Read More Columns<\/a><\/div><\/div>\n\n<\/aside>\n\n\n\n<p>This week would have marked the 53rd anniversary of <em>Roe v. Wade<\/em>, the 1973 Supreme Court decision that legalized abortion nationwide \u2014 that is, until 2022, when the court overturned it. Since then, abortion has been banned in 13 states and severely limited in 10 others.<\/p>\n\n\n\n<p>Yet anti-abortion activists remain frustrated, in some cases even more so than before <em>Roe<\/em> was overturned.<\/p>\n\n\n\n<p>Why? Because despite the new legal restrictions, abortions have not stopped taking place, not even in states with complete bans. In fact, the number of abortions has not dropped at all, <a href=\"https:\/\/www.kff.org\/womens-health-policy\/abortion-trends-before-and-after-dobbs\/\">according to the latest statistics<\/a>.<\/p>\n\n\n\n<p>\u201cIndeed, abortions have tragically increased in Louisiana and other pro-life states,\u201d Liz Murrill, Louisiana\u2019s attorney general, said at a Senate Health, Education, Labor, and Pensions Committee hearing this month.<\/p>\n\n\n\n<p>That\u2019s due in large part to the easier availability of medication abortion, which uses a combination of the drugs mifepristone and misoprostol, and particularly to the pills\u2019 availability via mail after a telehealth visit with a licensed health professional.<\/p>\n\n\n\n<p>Allowing telehealth access was a major change originally made on a temporary basis during the covid pandemic, when visits to a doctor\u2019s office were largely unavailable. Before that, unlike most medications, mifepristone could be dispensed only directly, and only by a medical professional individually certified by the Food and Drug Administration.<\/p>\n\n\n\n<p>The Biden administration later permanently eliminated the requirement for an in-person visit \u2014 a change the second Trump administration has not undone.<\/p>\n\n\n\n<p>While the percentage of abortions using medication had been growing every year since 2000, when the FDA first approved mifepristone for pregnancy termination, the Biden administration\u2019s decision to drop the in-person dispensing requirement supercharged its use. More than 60% of all abortions were done using medication rather than a procedure in 2023, the most recent year for which <a href=\"https:\/\/www.guttmacher.org\/2024\/03\/medication-abortion-accounted-63-all-us-abortions-2023-increase-53-2020\">statistics are available<\/a>. More than a quarter of all abortions that year were managed via telehealth.<\/p>\n\n\n<div\n\tclass=\"wp-block block--newsletter  \"\n\tdata-type=\"kaiser-health-news\/newsletter\"\n\tdata-align=\"center\"\n\tstyle=\"\"\n>\n\t<h4 class=\"newsletter__title\">\n\t\t<a href=\"\/email\/\">\n\t\t\tEmail Sign-Up\t\t<\/a>\n\t<\/h4>\n\t<p class=\"newsletter__description\">\n\t\tSubscribe to KFF Health News&#039; free weekly newsletter, &quot;The Week in Brief.&quot;\t<\/p>\n\t\n<form\n\taction=\"\/email-signup\/\"\n\tclass=\"kaiser-hubspot-mini-signup-form\"\n\tmethod=\"post\"\n>\n\t<input type=\"hidden\" id=\"kaiser_hubspot_nonce\" name=\"kaiser_hubspot_nonce\" value=\"dc9818bd64\" \/><input type=\"hidden\" name=\"_wp_http_referer\" value=\"\/wp-json\/wp\/v2\/article\/2144646\" \/>\t\t\t\t<label\n\t\tclass=\"kaiser-hubspot-mini-signup-form__label--email\"\n\t\tfor=\"kaiser-hubspot-mini-signup-form-email\"\n\t>\n\t\t<span class=\"screen-reader-text\">\n\t\t\tYour Email Address\t\t<\/span>\n\t\t<input\n\t\t\tautocomplete=\"email\"\n\t\t\tclass=\"kaiser-hubspot-mini-signup-form__input--email\"\n\t\t\tid=\"kaiser-hubspot-mini-signup-form-email\"\n\t\t\tname=\"kaiser_hubspot_email\"\n\t\t\ttype=\"email\"\n\t\t\t\t\t\t\tplaceholder=\"Your email address\"\n\t\t\t\t\t\/>\n\t<\/label>\n\t<button class=\"kaiser-hubspot-mini-signup-form__submit\">\n\t\tSign Up\t<\/button>\n<\/form>\n<\/div>\n\n\n\n<p>Separately, President Donald Trump\u2019s FDA in October approved a second generic version of mifepristone, angering abortion opponents. FDA officials said at the time that they had no choice \u2014 that as long as the original drug remains approved, federal law requires them to OK copies that are \u201cbioequivalent\u201d to the approved drug.<\/p>\n\n\n\n<p>It\u2019s clear that reining in, if not canceling, the approval of pregnancy-terminating medication is a top priority for abortion opponents. This month, Susan B. Anthony Pro-Life America called abortion drugs \u201c<a href=\"https:\/\/sbaprolife.org\/latest-news\/abortion-drugs-americas-new-public-health-crisis\">America\u2019s New Public Health Crisis<\/a>,\u201d referencing their growing use in ending pregnancies as well as claims of safety concerns \u2014 such as the risk a woman could be given the drugs unknowingly or suffer serious complications. Decades of research and experience show medication abortion is safe and complications are rare.<\/p>\n\n\n\n<p>Another group, Students for Life, has been trying to make the case that the biological waste from the use of mifepristone is <a href=\"https:\/\/www.politico.com\/news\/2025\/12\/15\/new-anti-abortion-campaign-takes-aim-at-epa-water-testing-rules-00682098\">contaminating the nation\u2019s water supply<\/a>, though environmental scientists refute that claim.<\/p>\n\n\n\n<p>Yet the groups are most frustrated not with supporters of abortion rights but with the Trump administration. The object of most of their ire is the FDA, which they say is dragging its feet on a promised review of the abortion pill and the Biden administration\u2019s loosened requirements around its availability.<\/p>\n\n\n\n<p>President Joe Biden\u2019s covid-era policy allowing abortion drugs to be sent via mail \u201dshould\u2019ve been rescinded on day one of the administration,\u201d SBA Pro-Life America\u2019s president, Marjorie Dannenfelser, said in a recent statement. Instead, almost a year later, she continued, \u201cpro-life states are being completely undermined in their ability to enforce the laws that they passed.\u201d<\/p>\n\n\n\n<p>Lawmakers who oppose abortion access are also pressing the administration. \u201cAt an absolute minimum, the previous in-person safeguards must be restored immediately,\u201d Senate HELP Committee Chairman Bill Cassidy said during the hearing with Murrill and other witnesses who want to see abortion pill availability curtailed.<\/p>\n\n\n\n<p>Sen. Jim Banks (R-Ind.) said at the hearing that he hoped \u201cthe rumors are false\u201d that \u201cthe agency is intentionally slow-walking its study on mifepristone\u2019s health risks.\u201d<\/p>\n\n\n\n<p>The White House and spokespeople at the Department of Health and Human Services have denied the review is being purposely delayed.<\/p>\n\n\n\n<p>\u201cThe FDA\u2019s scientific review process is thorough and takes the time necessary to ensure decisions are grounded in gold-standard science,\u201d HHS spokesperson Emily Hilliard said in an emailed response to KFF Health News. \u201cDr. Makary is upholding that standard as part of the Department\u2019s commitment to rigorous, evidence-based review.\u201d That\u2019s a reference to Marty Makary, the FDA commissioner.<\/p>\n\n\n\n<p>Revoking abortion pill access may not be as easy as advocates hoped when Trump moved back into the White House. While the president delivered on many of the goals of his anti-abortion backers during his first term, especially the confirmation of Supreme Court justices who made overturning <em>Roe<\/em> possible, he has been far less doctrinaire in his second go-round.<\/p>\n\n\n\n<p>Earlier this month, Trump unnerved some of his supporters by advising House Republicans that lawmakers \u201chave to be a little flexible\u201d on the Hyde Amendment to appeal to voters, referring to a decades-old appropriations rule that bans most federal abortion funding and that some Republicans have been pushing to enforce more broadly.<\/p>\n\n\n\n<p>And while the anniversary of Trump\u2019s inauguration has many analysts noting how much of the <a href=\"https:\/\/www.youtube.com\/watch?v=pnfT4k_L-_E\">Heritage Foundation\u2019s Project 2025 blueprint<\/a> has been realized, the most headline-grabbing portions on reproductive health have yet to be enacted. The Trump administration has not, for example, revoked the approval of mifepristone for pregnancy termination, nor has it invoked the 1873 Comstock Act, which <a href=\"https:\/\/kffhealthnews.org\/news\/article\/trump-abortion-powers-effective-ban\/\">could effectively ban abortion nationwide<\/a> by stopping not just the mailing of abortion pills but also anything else used in providing abortions.<\/p>\n\n\n\n<p>Still, abortion opponents have decades of practice at remaining hopeful \u2014 and playing a long game.<\/p>\n\n\n\n<p><em>HealthBent, a regular feature of KFF Health News, offers insight into and analysis of policies and politics from KFF Health News chief Washington correspondent Julie Rovner, who has covered health care for more than 30 years.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>With abortions still on the rise nationwide despite widespread bans, curtailing the use of pregnancy-terminating medication is a top priority for abortion opponents \u2014 and they\u2019re frustrated that the Trump administration isn\u2019t doing more to limit its use.<\/p>\n","protected":false},"featured_media":2144647,"template":"","meta":{"_cr_original_post":"","_cr_replace_post_id":"","_cr_replacing_post_id":"","jetpack_post_was_ever_published":false,"kff_featured_video":0,"kff_show_featured_video":false,"kff_show_mute_audio_button":false,"custom_shortlink":"\/MjE0NDY0Ng","kaiser_health_news_byline_override":"","kaiser_health_news_can_republish":true,"kaiser_health_news_featured_image_caption":"","kaiser_health_news_header_overlay_color":"","kaiser_health_news_header_theme_slug":"","kaiser_health_news_hero_image":0,"kaiser_health_news_backdrop_padding":115,"kaiser_health_news_hide_partner":false,"kaiser_health_news_kicker":"HealthBent","kaiser_health_news_kicker_background_color":"","kaiser_health_news_kicker_text_color":"","kaiser_health_news_kicker_url":"https:\/\/kffhealthnews.org\/topics\/healthbent\/","kaiser_health_news_nav_theme_slug":"compact","kaiser_health_news_nav_transparency":false,"kaiser_health_news_sharing_title":"","kaiser_health_news_show_featured_image":true,"kaiser_health_news_subheadline":"","kaiser_health_news_suppress_kicker":false,"kaiser_health_news_suppress_subheadline":false,"kaiser_health_news_update_time":"","kaiser_health_news_vertical_image":0,"kaiser_health_news_title_align_left":false,"kaiser_health_news_custom_header_image":0,"photo_byline":[],"story_update":"","update_position":"bottom","kaiser_syndication_sites":[],"apple_news_api_created_at":"2026-01-23T10:07:11Z","apple_news_api_id":"88b2d60c-29e7-44cf-8cac-1660f94536d0","apple_news_api_modified_at":"2026-01-23T10:07:12Z","apple_news_api_revision":"AAAAAAAAAAD\/\/\/\/\/\/\/\/\/\/w==","apple_news_api_share_url":"https:\/\/apple.news\/AiLLWDCnnRM-MrBZg-UU20A","apple_news_cover_media_provider":"image","apple_news_coverimage":0,"apple_news_coverimage_caption":"","apple_news_cover_video_id":0,"apple_news_cover_video_url":"","apple_news_cover_embedwebvideo_url":"","apple_news_is_hidden":"","apple_news_is_paid":"","apple_news_is_preview":"","apple_news_is_sponsored":"","apple_news_maturity_rating":"","apple_news_metadata":"\"\"","apple_news_pullquote":"","apple_news_pullquote_position":"","apple_news_slug":"","apple_news_sections":["https:\/\/news-api.apple.com\/sections\/20265c01-23d7-4d15-96e0-0691b89c3772"],"apple_news_suppress_video_url":false,"apple_news_use_image_component":false,"footnotes":""},"categories":[439526391,65226,36835],"tags":[13538,35350,303277465,59350,439529577,35359259],"primary-topic":[],"partners":[],"funder":[439528770],"coauthors":[259170663],"class_list":["post-2144646","article","type-article","status-publish","has-post-thumbnail","hentry","category-healthbent","category-pharmaceuticals","category-syndicate","tag-abortion","tag-fda","tag-hhs","tag-louisiana","tag-reproductive-health","tag-womens-health","funder-arnold-ventures"],"apple_news_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Why Medication Abortion Is the Top Target for Anti-Abortion Groups in 2026 - KFF Health News<\/title>\n<meta name=\"description\" content=\"With abortions still on the rise nationwide despite widespread bans, curtailing the use of pregnancy-terminating medication is a top priority for abortion opponents \u2014 and they\u2019re frustrated that the Trump administration isn\u2019t doing more to limit its use.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Why Medication Abortion Is the Top Target for Anti-Abortion Groups in 2026 - KFF Health News\" \/>\n<meta property=\"og:description\" content=\"With abortions still on the rise nationwide despite widespread bans, curtailing the use of pregnancy-terminating medication is a top priority for abortion opponents \u2014 and they\u2019re frustrated that the Trump administration isn\u2019t doing more to limit its use.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/\" \/>\n<meta property=\"og:site_name\" content=\"KFF Health News\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-23T12:49:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kffhealthnews.org\/wp-content\/uploads\/sites\/2\/2026\/01\/Rovner-HealthBent_2026.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"3840\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/\",\"url\":\"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/\",\"name\":\"Why Medication Abortion Is the Top Target for Anti-Abortion Groups in 2026 - KFF Health News\",\"isPartOf\":{\"@id\":\"https:\/\/kffhealthnews.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/kffhealthnews.org\/wp-content\/uploads\/sites\/2\/2026\/01\/Rovner-HealthBent_2026.jpg\",\"datePublished\":\"2026-01-23T10:00:00+00:00\",\"dateModified\":\"2026-01-23T12:49:52+00:00\",\"description\":\"With abortions still on the rise nationwide despite widespread bans, curtailing the use of pregnancy-terminating medication is a top priority for abortion opponents \u2014 and they\u2019re frustrated that the Trump administration isn\u2019t doing more to limit its use.\",\"breadcrumb\":{\"@id\":\"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/#primaryimage\",\"url\":\"https:\/\/kffhealthnews.org\/wp-content\/uploads\/sites\/2\/2026\/01\/Rovner-HealthBent_2026.jpg\",\"contentUrl\":\"https:\/\/kffhealthnews.org\/wp-content\/uploads\/sites\/2\/2026\/01\/Rovner-HealthBent_2026.jpg\",\"width\":3840,\"height\":2560},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Articles\",\"item\":\"https:\/\/kffhealthnews.org\/news\/article\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Why Medication Abortion Is the Top Target for Anti-Abortion Groups in 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kffhealthnews.org\/#website\",\"url\":\"https:\/\/kffhealthnews.org\/\",\"name\":\"KFF Health News\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kffhealthnews.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Why Medication Abortion Is the Top Target for Anti-Abortion Groups in 2026 - KFF Health News","description":"With abortions still on the rise nationwide despite widespread bans, curtailing the use of pregnancy-terminating medication is a top priority for abortion opponents \u2014 and they\u2019re frustrated that the Trump administration isn\u2019t doing more to limit its use.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/","og_locale":"en_US","og_type":"article","og_title":"Why Medication Abortion Is the Top Target for Anti-Abortion Groups in 2026 - KFF Health News","og_description":"With abortions still on the rise nationwide despite widespread bans, curtailing the use of pregnancy-terminating medication is a top priority for abortion opponents \u2014 and they\u2019re frustrated that the Trump administration isn\u2019t doing more to limit its use.","og_url":"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/","og_site_name":"KFF Health News","article_modified_time":"2026-01-23T12:49:52+00:00","og_image":[{"width":3840,"height":2560,"url":"https:\/\/kffhealthnews.org\/wp-content\/uploads\/sites\/2\/2026\/01\/Rovner-HealthBent_2026.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/","url":"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/","name":"Why Medication Abortion Is the Top Target for Anti-Abortion Groups in 2026 - KFF Health News","isPartOf":{"@id":"https:\/\/kffhealthnews.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/#primaryimage"},"image":{"@id":"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/kffhealthnews.org\/wp-content\/uploads\/sites\/2\/2026\/01\/Rovner-HealthBent_2026.jpg","datePublished":"2026-01-23T10:00:00+00:00","dateModified":"2026-01-23T12:49:52+00:00","description":"With abortions still on the rise nationwide despite widespread bans, curtailing the use of pregnancy-terminating medication is a top priority for abortion opponents \u2014 and they\u2019re frustrated that the Trump administration isn\u2019t doing more to limit its use.","breadcrumb":{"@id":"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/#primaryimage","url":"https:\/\/kffhealthnews.org\/wp-content\/uploads\/sites\/2\/2026\/01\/Rovner-HealthBent_2026.jpg","contentUrl":"https:\/\/kffhealthnews.org\/wp-content\/uploads\/sites\/2\/2026\/01\/Rovner-HealthBent_2026.jpg","width":3840,"height":2560},{"@type":"BreadcrumbList","@id":"https:\/\/kffhealthnews.org\/news\/article\/mifepristone-medication-abortion-pill-trump-fda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Articles","item":"https:\/\/kffhealthnews.org\/news\/article\/"},{"@type":"ListItem","position":2,"name":"Why Medication Abortion Is the Top Target for Anti-Abortion Groups in 2026"}]},{"@type":"WebSite","@id":"https:\/\/kffhealthnews.org\/#website","url":"https:\/\/kffhealthnews.org\/","name":"KFF Health News","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kffhealthnews.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"authors":[{"name":"Julie Rovner","link":"https:\/\/kffhealthnews.org\/news\/author\/julie-rovner\/","id":"7332"}],"jetpack_sharing_enabled":true,"amp_enabled":false,"_links":{"self":[{"href":"https:\/\/kffhealthnews.org\/wp-json\/wp\/v2\/article\/2144646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kffhealthnews.org\/wp-json\/wp\/v2\/article"}],"about":[{"href":"https:\/\/kffhealthnews.org\/wp-json\/wp\/v2\/types\/article"}],"version-history":[{"count":8,"href":"https:\/\/kffhealthnews.org\/wp-json\/wp\/v2\/article\/2144646\/revisions"}],"predecessor-version":[{"id":2146580,"href":"https:\/\/kffhealthnews.org\/wp-json\/wp\/v2\/article\/2144646\/revisions\/2146580"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kffhealthnews.org\/wp-json\/wp\/v2\/media\/2144647"}],"wp:attachment":[{"href":"https:\/\/kffhealthnews.org\/wp-json\/wp\/v2\/media?parent=2144646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kffhealthnews.org\/wp-json\/wp\/v2\/categories?post=2144646"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kffhealthnews.org\/wp-json\/wp\/v2\/tags?post=2144646"},{"taxonomy":"primary-topic","embeddable":true,"href":"https:\/\/kffhealthnews.org\/wp-json\/wp\/v2\/primary-topic?post=2144646"},{"taxonomy":"partners","embeddable":true,"href":"https:\/\/kffhealthnews.org\/wp-json\/wp\/v2\/partners?post=2144646"},{"taxonomy":"funder","embeddable":true,"href":"https:\/\/kffhealthnews.org\/wp-json\/wp\/v2\/funder?post=2144646"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/kffhealthnews.org\/wp-json\/wp\/v2\/coauthors?post=2144646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}